home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Kura Oncology Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Kura Oncology Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Post navigation
Previous Post
Previous
Turning Point Therapeutics Initiates Phase 1 Clinical Study of Tpx-0022, a Novel Met Inhibitor Targeting Advanced Solid Tumors
Next Post
Next
Blueprint Medicines Reports Second Quarter 2019 Financial Results